Background: Several plasmid DNA-based mammalian expression systems have recently been developed which make it possible to manipulate gene expression via the administration of exogenous agents. In order to extend the application of these systems, we have developed retroviral vectors which allow for the controlled expression of inserted genes both in vitro and in vivo. Materials and Methods: Two vector strategies which make use of the tetracycline-regulated gene expression system described by Gossen and Bujard were evaluated. In a first strategy, one virus was generated which encoded the tTA or rtTA transactivator gene product, and a second virus was generated in which expression of the gene of interest was dependent upon tetracycline-responsive transcriptional control elements placed either within the viral LTR or within the proviral transcriptional unit. In a second vector strategy, both components of the tet-regulatable system were incorporated into a single proviral genome in such a way that expression of
INTRODUCTION
Several plasmid based mammalian expression systems have recently been developed which make it possible to manipulate gene expression via the administration of exogenous agents (1) (2) (3) (4) . To date, the system that has been most widely employed makes use of specific control elements of the E. coli TnlO operon (5) to regulate transcription. This system, originally described by Gossen and Bujard (1) , relies on the use of two plasmid constructs: (i) an expression construct which encodes a hybrid transactivator gene product (termed either tTA or rtTA) in which the DNA binding domain of the tetracycline repressor (tetR) of Escherichia coli is linked to the transactivation domain of the herpes simplex (HSV) VP16 gene product, and (ii) a construct in which expression of the desired gene 467 product is controlled by a tetracycline-responsive transcriptional control element generated by the fusion of seven copies of tet operator sequences derived from the TnlO operon (5) to a minimal cytomegalovirus (CMV) immediate early gene promoter (tetOP/CMV) or other minimal promoter sequences. In the original system described by Gossen and Bujard (1) , binding of tTA to the regulatory element is inhibited by the presence of tetracycline and transcription from the tet regulatory unit is virtually silent. In the absence of tetracycline, the specific high affinity binding of tTA to the chimeric tet promoter leads to a dramatic increase in transcription from the regulatory unit. More recently, Gossen et al. (2) have also described a modified system which makes use of a mutant transactivator (termed reverse or rtTA) that binds to the regulatory unit only in the presence of certain tetracycline derivatives. This modification may facilitate the in vivo use of the tet regulatory system and lead to the faster induction of gene expression.
The system of Gossen and Bujard necessitates the transfer into cells of both a vector which encodes the relevant transcriptional transactivator gene product(s) and a second construct in which the cDNA of interest has been placed under the control of specific regulatable transcriptional control sequences (1, 2) . The utility of this regulatable vector system therefore depends both upon the ability to express sufficient amounts of the necessary transactivator(s) and the integration of the regulatable vector construct in such a way that the basal levels of transgene expression are low, yet the induced levels of expression are high. In studies involving cultured cells, these requirements often necessitate the screening of a large number of stable transfectants and are compounded by the need to introduce both constructs into the same cell. Although the tet-regulatable expression system has already been widely employed in studies involving cultured cell lines, the use of the system to regulate gene expression in primary cells, either in vitro or in vivo, has been hampered by the inability to efficiently transduce the relevant target cells without the use of drug selection. For example, studies involving primary cells in vivo have, to date, necessitated the lengthy process of generating transgenic animals and the breeding of strains carrying the expression and transactivator-encoding constructs (6, 7) .
In order to extend the application of regulated gene expression systems, we have generated highly transmissible retrovirus vectors which encode the relevant elements of the tetracycline-regulated gene expression system described by Gossen and Bujard (1, 2) . Here, we describe both 'one virus' and 'two virus' strategies which result in the ability to efficiently generate transduced cells which express the gene of interest in a highly regulated fashion. We also show that cells transduced by the vectors demonstrate regulated expression even after their transplantation in vivo.
MATERIALS AND METHODS

Construction of Retroviral Vectors
All constructs are based on the SFG retroviral vector developed in our laboratory (8) . In the case of each construct, protein coding sequences were introduced between the Nco I and Bam HI sites of the vector in a precise way, such that the AUG sequences encoded by the Nco I site initiate translation of the gene product of interest. SFG hGH contained the human growth hormone (hGH) ORF (9) . SFG Luc was constructed by insertion of the luciferase ORF from the pGL-2 plasmid (Promega Corp., Madison, WI). The SFG tTA and rtTA constructs contained the ORF of the transactivator (tTA) from pUHD 15-1 (1) and the reverse transactivator (rtTA) from pUHGl 7-1 (2) . SFG NLS-Lac-z contained the E. coli beta galactosidase gene fused C-terminal to a SV40 nuclear localization signal (10) .
Variants of the basic SFG vectors with modifications in the U3 of the 3'LTR have the type of deletion specified by letters and numbers (e.g. SFG Luc ECl). A prefix "t7" in front of the deletion indicates the insertion of 7 Cells and Animals C2C12 (11, 12) and NIH3T3 cells were obtained from American Type Culture Collection, Rockville, MD and ecotropic BOSC23 (13) packaging cells were a gift from W. Pear. C2C12 and BOSC cells were cultivated in DMEM containing 10% fetal calf serum (FCS) and NIH3T3 cells were cultured in DMEM containing 10% calf serum. All media was supplemented with 100 U/ml penicillin and 100 ,ug/ml streptomycin. C 3H/HeJ mice, [3] [4] weeks old, were purchased from Jackson Laboratory (Bar Harbor, ME).
Transfections, Infections, Induction of Gene Expression, and Determination of Transduction Efficiencies Recombinant retroviral vectors were generated by transient transfection of the ecotropic BOSC23 packaging cell line as described elsewhere (13) . Viral supernatants from independent transfections with the same retroviral construct were pooled, filtered (0.45 ,u), and used immediately or stored at -80°C until use. When using the original tTA gene, BOSC23 cells were grown in the presence of 1 Ag/ml tetracycline (Sigma, St. Louis, MO).
For infection of NIH3T3 cells, 1 x 105 cells per 6 cm dish were plated for 24 hours and then incubated for 4 hours with 3 ml of viral supernatant in the presence of 8 ,ug/ml Polybrene. The following day the transduced cell population was split into two 6 cm dishes. In the case of vectors employing the tTA gene product, gene expression was induced 24 hours later on one plate by washing two times and further incubation with tetracycline free growth medium while the other plate continued to be incubated in the presence of tetracycline (1 ,ug/ml). When using the rtTA gene product, expression was induced on one plate through the addition of doxycycline (Sigma, St. Louis, MO) at 1 jig/ml to the medium.
After an additional 48 hours incubation cells of both plates were harvested and gene expression was analyzed.
Transduction efficiency was determined by Southern blot analysis of infected cultures as described previously (14 Luc t7E, is shown in Fig. 1 (Fig. 1) . The deletion of sequences in the LTR were introduced in order to decrease or eliminate LTR-mediated transcription after proviral integration (16) (17) (18) . In both two-virus configurations, the luciferase gene was used as the reporter gene. In a second strategy (termed the "single virus strategy"), attempts were made to introduce all of the necessary components into a single vector. For the construction of this type of vector, both the tet/CMV promoter sequences and luciferase coding sequences were positioned internal to the proviral transcriptional unit. To provide for expression of the transactivator gene products, picornavirus-derived internal ribosome entry site (IRES) sequences (19) were positioned directly 3' to the luciferase encoding sequences and 5' to either the tTA or rtTA coding sequences (SFG tc luc IT) (Fig. 1) . With this configuration, we expected that expression of both the transgene and the transactivator would be largely controlled by the tet/CMV promoter sequences, and that low levels of transactivator expression would 'autostimulate' transactivator expression. One likely requirement of such a transcriptional circuit, however, would be that some low level of tetindependent transcription would be needed in order to initiate the autostimulatory circuit. For this reason, we evaluated a number of constructs carrying deletions in the 3'LTR expected to reduce the transcriptional activity of the 5 'LTR after proviral integration (see below). In vivo regulation of hGH production by these vectors was examined by injection of transduced C2C 12 myoblast populations into the hind limbs of C3H/HeJ mice (21) . Gene expression was regulated through the oral administration of doxycycline in the drinking water. At various time points after injection the hGH serum levels in individual mice were determined by RIA. As shown in Figure 4B, 
DISCUSSION
The studies described above were motivated by the need for the development of highly efficient mammalian gene transfer vectors which make it possible to manipulate the expression of inserted genes. Several strategies which make use of retroviral-mediated gene transfer for the regulated expression of genes have already been already described (22) (23) (24) (25) (8, 14, 15) , the ability to achieve even higher levels of expression than the MFG vectors was unanticipated. Why, in the case of several constructs, the use of the rtTA gene led to higher levels of gene expression in the induced state than that achieved with tTA, remains unclear.
In the case of the single virus system, gene expression could be regulated over a 100-fold range. The most important observation made in the course of studies with the single virus systems was that progressive deletion of transcriptional control sequences in the viral LTR led to proportional decreases in both the basal and induced levels of transgene expression. While the removal of such sequences might be anticipated to reduce the component of basal expression levels due to a low level of LTR-driven transcription, and to perhaps influence expression of the minimal CMV promoter (by reducing enhancement from sequences in the LTR), we do not understand why expression from the regulatable tet/ CMV transcriptional unit would be decreased, rather than increased, by progressive deletion. Although it is possible that the larger deletions affect the stability and/or translational efficiency of the tet/CMV promoted transcripts, studies of gene expression after transfection of SFG-derived constructs carrying those same deletions showed little or no differences in luciferase expression (data not shown). Another potential explanation for the results observed is that the progressive deletions in the LTR reduce the expression of the transactivator gene products to the point they are unable to properly initiate the autostimulation of their expression necessary to provide for the high levels of transgene expression observed with the other constructs. Whatever the explanation, one fortuitous consequence of the phenomenon is that we now have available a family of vectors that lead to distinctly different levels of expression in the induced state. Such vectors may obviate the need to carefully titrate antibiotic concentrations in biological studies in which attaining a specific level of expression is critical. Again, as in the case of the two virus system, we observed, at least with one single virus vector, the ability to achieve levels of gene expression in the induced state higher than those achieved with the parental SFG.
In studies by Blau and co-workers (22) (26, 27) , and the demonstration of the ability of lentivirus vectors to efficiently transduce at least some quiescent cells (28) , the work reported here suggests that obtaining the regulated expression of genes via the direct in vivo delivery of retroviral vectors will ultimately prove to be feasible.
